🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 6

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Tue, Nov 18, 2025 at 7:47 PM 43 replies 1,294 viewsPage 6 of 9
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Jan 11, 2026 at 7:21 PM#26
Dr.PathRoch said:
Say what you would expect to see if you were wrong, before you look.

Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.

36 9Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 33 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Jan 18, 2026 at 8:13 PM#27

Clinical perspective, offered as context rather than as advice. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

37 10Dr.EndoEP, GraceAZ_72, carl_compliance and 34 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Jan 25, 2026 at 9:01 PM#28
sarah_TO said:
It helps to ask what evidence would change your mind before you look at any.

Same experience, arrived at from the opposite direction.

38 11TomTeleRx, DoseLogDan, SleepFixSam and 35 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Feb 1, 2026 at 9:44 PM#29
sarah_TO said:
It helps to ask what evidence would change your mind before you look at any.

There is a second half to this that has not been said yet. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

39 12SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 36 others
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Feb 8, 2026 at 10:23 PM#30

Reporting back.

Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

11 9emily_PDX, Dr.SleepRoch, laura_annarbor and 8 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register